Nervio
Nervio's AI-powered SaMD platform transforms real-time neurophys data into actionable surgical intelligence, giving clinicians a live understanding of nervous system function.
Problem & solution
Neuro-monitoring is used during surgery to reduce avoidable injuries such as weakness and paralysis. Today, it's reactive: surgeons are alerted when specialists detect changes in physiological signals. Nervio’s SaMD platform is a proactive, intelligent system that captures and analyzes signals, understands clinical context, and delivers immediate actionable intelligence to the surgical team, all while sending feedback to interconnected technologies for improved ecosystem performance.
Primary customers & users
Nervio's customers include OEMs and strategic technology partners. Hospitals, ASCs, and contract service providers deploy through existing clinical workflows and install bases.
Differentiation
Nervio is the first SaMD platform built for neuro-monitoring, transforming reactive monitoring into a proactive, continuously learning system. It interprets clinical context in real time, delivers actionable intelligence to the surgical team, and feeds insights back to interconnected technologies to improve ecosystem performance.
Current traction
Nervio has an active development partnership with a leading global medical device company, including a commercial-stage agreement for future revenue. We hold signed agreements with multiple OEMs, including an integration and LOI representing approximately 90% market share, plus distribution and research agreements in the EU, with prospective and retrospective research in Israel. Our Series A raise is underway, backed by early investor relationships built through Israeli venture networks.
How Summit participants can help
We are most interested in connecting with hospital and health system leaders who can champion access to de-identified data, investors for our Series A raise, and other leaders who can expand our network and open new commercial and strategic opportunities.